Oncology Genetic Testing
BGI SENTIS
Our comprehensive hereditary cancer genetic testing panels analyze 85 genes associated with 24 hereditary cancers, providing you with crucial insights into your cancer risk factors. By identifying potential cancer risks early, we enable you to make informed decisions about your health. With BGI Sentis, you can gain valuable information that not only enhances your understanding of your health but also aids healthcare professionals in developing effective strategies for monitoring and managing your risk.
Product Description
BGI’s hereditary risk screening cancer panels target genes previously linked to a predisposition of cancer. The panel selection is based on expert curation of scientific literature and other high quality resources, including formal medical guidelines.
BGI’s Comprehensive Hereditary Cancer Panels provides information on 85 genes associated with 24 different types of hereditary cancer including some of the most commonly occurring cancers such as:
- Hereditary breast
- Ovarian
- Colorectal
- Pancreatic
- Prostate
- Stomach
BGI can also detect different alterations including germline SNV, Indels, and CNV.